Colleen Tupper, EVP and Chief Financial Officer of Collegium Pharmaceutical ($COLL), sold shares on the open market five times over the past year, totaling $1.47 million. Her most recent sale occurred on November 6, 2025. These sales rank her 4,095th among 11,678 insiders in our database by total value sold, below the average of $8.59 million across about 6.4 transactions per insider. Tupper made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 26679 | $46.75 | 147,282.0000 | 40,076,457 | 15.34% | 0.07% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 11861 | $46.75 | 173,961.0000 | 40,076,457 | 6.38% | 0.03% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 32734 | $0.00 | 185,822.0000 | 40,076,457 | 21.38% | 0.08% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 26421 | $0.00 | 153,088.0000 | 40,076,457 | 20.86% | 0.07% |
| Nov. 6, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 4858 | $41.28 | 126,667.0000 | 39,439,890 | 3.69% | 0.01% |
| Nov. 6, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 25142 | $40.38 | 131,525.0000 | 39,439,890 | 16.05% | 0.06% |
| March 20, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 1206 | $30.00 | 163,063.0000 | 40,109,649 | 0.73% | 0.00% |
| March 21, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 6396 | $30.03 | 156,667.0000 | 40,109,649 | 3.92% | 0.02% |
| March 14, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 977 | $30.00 | 164,269.0000 | 40,109,649 | 0.59% | 0.00% |
| March 11, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 10445 | $30.01 | 165,246.0000 | 40,109,649 | 5.95% | 0.03% |
| March 6, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 1949 | $30.00 | 177,195.0000 | 40,109,649 | 1.09% | 0.00% |
| March 7, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 1504 | $30.00 | 175,691.0000 | 40,109,649 | 0.85% | 0.00% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 8109 | $30.52 | 201,461.0000 | 40,109,649 | 3.87% | 0.02% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 22317 | $30.52 | 179,144.0000 | 40,109,649 | 11.08% | 0.06% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 26957 | $0.00 | 209,570.0000 | 40,109,649 | 14.76% | 0.07% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 51768 | $0.00 | 182,613.0000 | 40,109,649 | 39.56% | 0.13% |
| May 28, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 19710 | $34.21 | 130,845.0000 | 41,438,466 | 13.09% | 0.05% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 40600 | $0.00 | 146,020.0000 | 41,279,981 | 38.51% | 0.10% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 16868 | $33.70 | 160,008.0000 | 41,279,981 | 9.54% | 0.04% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 30856 | $0.00 | 176,876.0000 | 41,279,981 | 21.13% | 0.07% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 9453 | $33.70 | 150,555.0000 | 41,279,981 | 5.91% | 0.02% |
| March 15, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | S | Common Stock | 31640 | $23.77 | 105,420.0000 | 33,582,202 | 23.08% | 0.09% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 3887 | $26.75 | 137,060.0000 | 33,582,202 | 2.76% | 0.01% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 45045 | $0.00 | 135,349.0000 | 33,582,202 | 49.88% | 0.13% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | A | Common Stock | 12565 | $0.00 | 147,914.0000 | 33,582,202 | 9.28% | 0.04% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Tupper Colleen | EVP & Chief Financial Officer | F | Common Stock | 6967 | $26.75 | 140,947.0000 | 33,582,202 | 4.71% | 0.02% |